首页 > 最新文献

Diabetes & metabolism最新文献

英文 中文
BedBiopsy: Diagnostic performance of bedside ultrasound-guided bone biopsies for the management of diabetic foot infection 床旁活检:用于糖尿病足感染治疗的床旁超声引导骨活检的诊断性能。
IF 7.2 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-03-03 DOI: 10.1016/j.diabet.2024.101525
Nolan Hassold , Hélène Bihan , Yolène Pambo Moumba , Isabelle Poilane , Frédéric Méchaï , Nabil Assad , Véronique Labbe-Gentils , Meriem Sal , Omar Nouhou Koutcha , Antoine Martin , Dana Radu , Emmanuel Martinod , Hugues Cordel , Nicolas Vignier , Sopio Tatulashvili , Narimane Berkane , Etienne Carbonnelle , Olivier Bouchaud , Emmanuel Cosson

Objective

We aimed to assess the feasibility and diagnostic performance of ultrasound-guided bone biopsies at the bedside of diabetic patients admitted for suspected foot osteitis not requiring surgery.

Research Design and Methods

In this retrospective monocentric study, we compared the performance of ultrasound-guided (n = 29 consecutive patients, Dec.2020-Oct.2022) versus surgical (n = 24 consecutive patients, Jan.2018-Nov.2020) bone biopsies at confirming or ruling out diabetic foot osteitis (primary outcome).

Results

Patient characteristics were similar in the two intervention groups, including arteritis prevalence (62.3 %), SINBAD score, and wound location (phalanges 36 %, metatarsus 43 %, and calcaneus 21 %). However, the ultrasound-guided group was older (67 ± 11 versus 60 ± 13 years respectively, P = 0.047) and had more type 2 diabetes (97 % versus 75 %, P = 0.038). Diagnostic performance (i.e., capacity to confirm or rule out suspected osteitis) was similar for ultrasound-guided (28/29 cases: 25 confirmations, 3 invalidations) and surgical (24 confirmations/24) biopsies, P = 0.358. No biopsy-related side effect or complication was observed for either intervention, even for patients on antiaggregation and/or anticoagulation therapy. The mean (± standard deviation) time necessary to perform the biopsy was shorter in the ultrasound-guided group (2.6 ± 3.0 versus 7.2 ± 5.8 days, respectively, P < 0.001) and wound evolution at three months was more favorable (83.3 versus 41.2 %, P = 0.005) (94.4 % versus 66.7 %, respectively, patients with new surgical procedure within six months excluded; P = 0.055). Even though not statistically significant, healing rates in terms of wound and osteitis at six months were also better in the ultrasound-guided group (wound: 40.9 % versus 36.8 %; P = 0.790, and osteitis: 81.8 vs 55.6 % P = 0.071).

Conclusion

In diabetic patients with suspected foot osteitis not requiring surgery, bedside ultrasound-guided bone biopsies may constitute a promising alternative to surgical biopsies. This intervention provided excellent tolerance and microbiological documentation, short lead-times, and more favorable wound prognosis.

研究设计与方法:- 在这项回顾性单中心研究中,我们比较了超声引导下(2020 年 12 月至 2022 年 10 月,连续 29 例患者)与手术(2018 年 1 月至 2022 年 11 月,连续 24 例患者)骨活检在确诊或排除糖尿病足骨炎(主要结果)方面的表现。2022 年 10 月)与手术(n=24 名连续患者,2018 年 1 月至 2020 年 11 月)骨活检在确认或排除糖尿病足骨炎方面的表现(主要结果):- 两个干预组的患者特征相似,包括动脉炎患病率(62.3%)、SINBAD评分和伤口位置(趾骨36%、跖骨43%和小腿骨21%)。然而,超声引导组的年龄更大(分别为 67 ± 11 岁和 60 ± 13 岁,P = 0.047),2 型糖尿病患者更多(分别为 97% 和 75%,P = 0.038)。超声引导活检(28/29 例:25 例确诊,3 例无效)和手术活检(24 例确诊/24 例)的诊断效果(即确诊或排除疑似骨炎的能力)相似,P = 0.358。两种方法均未发现与活检相关的副作用或并发症,即使是正在接受抗聚集和/或抗凝治疗的患者也是如此。超声引导组进行活检所需的平均(± 标准差)时间更短(分别为 2.6 ± 3.0 天对 7.2 ± 5.8 天,P < 0.001),三个月后的伤口愈合情况更好(分别为 83.3% 对 41.2%,P = 0.005)(分别为 94.4% 对 66.7%,排除六个月内进行过新手术的患者;P = 0.055)。尽管没有统计学意义,但超声引导组患者六个月后伤口和骨炎的愈合率也更好(伤口:40.9% 对 36.8%;P = 0.790;骨炎:81.8% 对 55.6% P = 0.071)。这一干预措施提供了极佳的耐受性和微生物记录,缩短了准备时间,并使伤口预后更为有利。
{"title":"BedBiopsy: Diagnostic performance of bedside ultrasound-guided bone biopsies for the management of diabetic foot infection","authors":"Nolan Hassold ,&nbsp;Hélène Bihan ,&nbsp;Yolène Pambo Moumba ,&nbsp;Isabelle Poilane ,&nbsp;Frédéric Méchaï ,&nbsp;Nabil Assad ,&nbsp;Véronique Labbe-Gentils ,&nbsp;Meriem Sal ,&nbsp;Omar Nouhou Koutcha ,&nbsp;Antoine Martin ,&nbsp;Dana Radu ,&nbsp;Emmanuel Martinod ,&nbsp;Hugues Cordel ,&nbsp;Nicolas Vignier ,&nbsp;Sopio Tatulashvili ,&nbsp;Narimane Berkane ,&nbsp;Etienne Carbonnelle ,&nbsp;Olivier Bouchaud ,&nbsp;Emmanuel Cosson","doi":"10.1016/j.diabet.2024.101525","DOIUrl":"10.1016/j.diabet.2024.101525","url":null,"abstract":"<div><h3>Objective</h3><p>We aimed to assess the feasibility and diagnostic performance of ultrasound-guided bone biopsies at the bedside of diabetic patients admitted for suspected foot osteitis not requiring surgery.</p></div><div><h3>Research Design and Methods</h3><p>In this retrospective monocentric study, we compared the performance of ultrasound-guided (<em>n</em> = 29 consecutive patients, Dec.2020-Oct.2022) versus surgical (<em>n</em> = 24 consecutive patients, Jan.2018-Nov.2020) bone biopsies at confirming or ruling out diabetic foot osteitis (primary outcome).</p></div><div><h3>Results</h3><p>Patient characteristics were similar in the two intervention groups, including arteritis prevalence (62.3 %), SINBAD score, and wound location (phalanges 36 %, metatarsus 43 %, and calcaneus 21 %). However, the ultrasound-guided group was older (67 ± 11 versus 60 ± 13 years respectively, <em>P</em> = 0.047) and had more type 2 diabetes (97 % versus 75 %, <em>P</em> = 0.038). Diagnostic performance (i.e., capacity to confirm or rule out suspected osteitis) was similar for ultrasound-guided (28/29 cases: 25 confirmations, 3 invalidations) and surgical (24 confirmations/24) biopsies, <em>P</em> = 0.358. No biopsy-related side effect or complication was observed for either intervention, even for patients on antiaggregation and/or anticoagulation therapy. The mean (± standard deviation) time necessary to perform the biopsy was shorter in the ultrasound-guided group (2.6 ± 3.0 versus 7.2 ± 5.8 days, respectively, <em>P</em> &lt; 0.001) and wound evolution at three months was more favorable (83.3 versus 41.2 %, <em>P</em> = 0.005) (94.4 % versus 66.7 %, respectively, patients with new surgical procedure within six months excluded; <em>P</em> = 0.055). Even though not statistically significant, healing rates in terms of wound and osteitis at six months were also better in the ultrasound-guided group (wound: 40.9 % versus 36.8 %; <em>P</em> = 0.790, and osteitis: 81.8 vs 55.6 % <em>P</em> = 0.071).</p></div><div><h3>Conclusion</h3><p>In diabetic patients with suspected foot osteitis not requiring surgery, bedside ultrasound-guided bone biopsies may constitute a promising alternative to surgical biopsies. This intervention provided excellent tolerance and microbiological documentation, short lead-times, and more favorable wound prognosis.</p></div>","PeriodicalId":11334,"journal":{"name":"Diabetes & metabolism","volume":"50 3","pages":"Article 101525"},"PeriodicalIF":7.2,"publicationDate":"2024-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S126236362400017X/pdfft?md5=9cd9269cb51ef1e69ce6f23096a21c4b&pid=1-s2.0-S126236362400017X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140041223","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Skin autofluorescence of advanced glycation end-products relates to new cardiovascular events in type 2 diabetes: A longitudinal observational study 皮肤高级糖化终产物自发荧光与 2 型糖尿病新发心血管事件的关系:一项纵向观察研究。
IF 7.2 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-02-11 DOI: 10.1016/j.diabet.2024.101524
Fadi Alkhami, Gauthier Borderie, Ninon Foussard, Alice Larroumet, Laurence Blanco, Marie-Amélie Barbet-Massin, Amandine Ferriere, Claire Ducos, Kamel Mohammedi, Sami Fawaz, Thierry Couffinhal, Vincent Rigalleau

Background

Cardiovascular disease is frequent in type 2 diabetes mellitus (T2DM). We investigated the relationship between skin autofluorescence (SAF) of advanced glycation end-products and later cardiovascular events (CVEs) in patients with T2DM.

Research design and methods

We conducted a retrospective analysis of 504 patients hospitalized for uncontrolled and/or complicated T2DM between 2009 and 2017. SAF was measured using an AGE-Reader. Participants were followed up from admission to December 2020, for the onset of a CVE (myocardial infarction, stroke, revascularization procedures or cardiovascular death). The relationship between SAF and CVE was analyzed by multivariable Cox regression. Log-rank curves were used to compare CVE-free survival in patients whose SAF at admission was above versus below the whole-population median. The analysis was repeated in subjects without/with macroangiopathy (defined as myocardial infarction, stroke, peripheral revascularization) at baseline.

Findings

During 54 months of follow-up, 69 (13.7%) patients had a CVE. Baseline SAF was significantly higher in patients with T2DM who later experienced a CVE (2.89 ± 0.70 arbitrary units versus 2.64 ± 0.62 in others, P = 0.002). This relationship was significant after adjusting for age, sex, conventional risk factors (diabetes duration, HbA1c, arterial hypertension, dyslipidemia, smoking, body mass index), vascular complications, C-reactive protein, and treatments for diabetes. The CVE-free survival curves differed between subjects whose SAF was above the whole-population median (log-rank: P = 0.002) and those whose SAF was above the macroangiopathy-free sub-population median (log-rank: P = 0.016).

Conclusion

SAF of advanced glycation end-products was related to a higher incidence of later CVE in patients with T2DM.

背景:心血管疾病是2型糖尿病(T2DM)的常见病。我们研究了T2DM患者皮肤高级糖化终产物自发荧光(SAF)与日后心血管事件(CVEs)之间的关系:我们对 2009 年至 2017 年间 504 名因未控制和/或复杂 T2DM 而住院的患者进行了回顾性分析。使用 AGE-Reader 测量了 SAF。从入院到 2020 年 12 月,我们对参与者的 CVE(心肌梗死、中风、血管重建手术或心血管死亡)发病情况进行了随访。通过多变量考克斯回归分析了SAF与CVE之间的关系。使用对数秩曲线比较入院时SAF高于和低于全人群中位数的患者无CVE生存率。对基线时无/有大血管病变(定义为心肌梗死、中风、外周血管再通术)的受试者进行了重复分析:在54个月的随访期间,69名(13.7%)患者出现了CVE。后来发生 CVE 的 T2DM 患者的基线 SAF 明显更高(2.89 ± 0.70 任意单位,其他患者为 2.64 ± 0.62,P = 0.002)。在调整了年龄、性别、常规风险因素(糖尿病病程、HbA1c、动脉高血压、血脂异常、吸烟、体重指数)、血管并发症、C-反应蛋白和糖尿病治疗方法后,这一关系仍有意义。SAF高于全人群中位数(对数秩:P = 0.002)的受试者与SAF高于无大血管病变亚人群中位数(对数秩:P = 0.016)的受试者之间的无CVE生存曲线存在差异:结论:晚期糖化终末产物的SAF与T2DM患者日后CVE的较高发病率有关。
{"title":"Skin autofluorescence of advanced glycation end-products relates to new cardiovascular events in type 2 diabetes: A longitudinal observational study","authors":"Fadi Alkhami,&nbsp;Gauthier Borderie,&nbsp;Ninon Foussard,&nbsp;Alice Larroumet,&nbsp;Laurence Blanco,&nbsp;Marie-Amélie Barbet-Massin,&nbsp;Amandine Ferriere,&nbsp;Claire Ducos,&nbsp;Kamel Mohammedi,&nbsp;Sami Fawaz,&nbsp;Thierry Couffinhal,&nbsp;Vincent Rigalleau","doi":"10.1016/j.diabet.2024.101524","DOIUrl":"10.1016/j.diabet.2024.101524","url":null,"abstract":"<div><h3>Background</h3><p>Cardiovascular disease is frequent in type 2 diabetes mellitus (T2DM). We investigated the relationship between skin autofluorescence (SAF) of advanced glycation end-products and later cardiovascular events (CVEs) in patients with T2DM.</p></div><div><h3>Research design and methods</h3><p>We conducted a retrospective analysis of 504 patients hospitalized for uncontrolled and/or complicated T2DM between 2009 and 2017. SAF was measured using an AGE-Reader. Participants were followed up from admission to December 2020, for the onset of a CVE (myocardial infarction, stroke, revascularization procedures or cardiovascular death). The relationship between SAF and CVE was analyzed by multivariable Cox regression. Log-rank curves were used to compare CVE-free survival in patients whose SAF at admission was above versus below the whole-population median. The analysis was repeated in subjects without/with macroangiopathy (defined as myocardial infarction, stroke, peripheral revascularization) at baseline.</p></div><div><h3>Findings</h3><p>During 54 months of follow-up, 69 (13.7%) patients had a CVE. Baseline SAF was significantly higher in patients with T2DM who later experienced a CVE (2.89 ± 0.70 arbitrary units versus 2.64 ± 0.62 in others, <em>P</em> = 0.002). This relationship was significant after adjusting for age, sex, conventional risk factors (diabetes duration, HbA1c, arterial hypertension, dyslipidemia, smoking, body mass index), vascular complications, C-reactive protein, and treatments for diabetes. The CVE-free survival curves differed between subjects whose SAF was above the whole-population median (log-rank: <em>P</em> = 0.002) and those whose SAF was above the macroangiopathy-free sub-population median (log-rank: <em>P</em> = 0.016).</p></div><div><h3>Conclusion</h3><p>SAF of advanced glycation end-products was related to a higher incidence of later CVE in patients with T2DM.</p></div>","PeriodicalId":11334,"journal":{"name":"Diabetes & metabolism","volume":"50 2","pages":"Article 101524"},"PeriodicalIF":7.2,"publicationDate":"2024-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139725618","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between blood urea nitrogen-to-creatinine ratio and insulin sensitivity 血尿素氮-肌酐比值与胰岛素敏感性之间的关系
IF 7.2 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-02-08 DOI: 10.1016/j.diabet.2024.101521
JaeHyuck Lee , In Cheol Hwang , Hong Yup Ahn
{"title":"Association between blood urea nitrogen-to-creatinine ratio and insulin sensitivity","authors":"JaeHyuck Lee ,&nbsp;In Cheol Hwang ,&nbsp;Hong Yup Ahn","doi":"10.1016/j.diabet.2024.101521","DOIUrl":"10.1016/j.diabet.2024.101521","url":null,"abstract":"","PeriodicalId":11334,"journal":{"name":"Diabetes & metabolism","volume":"50 2","pages":"Article 101521"},"PeriodicalIF":7.2,"publicationDate":"2024-02-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139716807","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
High serum total bilirubin as a potential protective factor for gestational diabetes mellitus: A retrospective cohort study of 92,885 Chinese pregnant women 高血清总胆红素是妊娠糖尿病的潜在保护因素:一项针对 92 885 名中国孕妇的回顾性队列研究。
IF 7.2 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-02-08 DOI: 10.1016/j.diabet.2024.101523
Yan Zhao , Wenyu Zhu , Miao Wang , Luyi Cai , Xueying Zheng , Liping Jin

Aims

Identifying physiological factors that could reduce pregnant women's risk for developing gestational diabetes mellitus (GDM) is crucial for early prevention and intervention. We aimed to examine whether higher serum levels of total bilirubin (TBIL) were associated with a decreased risk of GDM.

Methods

We conducted a retrospective cohort study in a tertiary care hospital in Shanghai, China. A total of 92,885 pregnant women were included. Serum TBIL levels were determined during the first antenatal visit before 24 weeks of gestation and GDM was diagnosed with a 75-g oral glucose tolerance test (OGTT) at 24–28 weeks of gestation.

Results

A total of 13,037 GDM cases were identified, a prevalence of 14.0 % (13,037/92,885). These women had a higher median TBIL concentration 7.9 versus 7.6 mmol/l (P < 0.001). For the 91,051 women with TBIL within the physiologically normal range (≤ 17.1 μmol/l), a one interquartile range increase in TBIL (3.4 μmol/l) was associated with a decreased risk of GDM: adjusted odds ratio (OR)=0.89 [95 % CI 0.87;0.92]. For these women, the adjusted ORs for GDM across TBIL quartiles were: 0.92 [0.88;0.97] for the second, 0.85 [0.81;0.90] for the third, and 0.78 [0.74;0.83] for the fourth quartile in comparison with the first quartile.

Conclusion

Our study demonstrated that elevated serum TBIL levels were associated with decreased risk of GDM and supported its potential role in the prevention and early intervention of GDM.

目的:确定可降低孕妇罹患妊娠糖尿病(GDM)风险的生理因素对于早期预防和干预至关重要。我们旨在研究血清总胆红素(TBIL)水平较高是否与 GDM 风险降低有关:我们在中国上海的一家三级医院开展了一项回顾性队列研究。共纳入 92,885 名孕妇。在妊娠 24 周前的首次产前检查中测定血清 TBIL 水平,在妊娠 24-28 周时通过 75 克口服葡萄糖耐量试验(OGTT)诊断 GDM:共发现 13,037 例 GDM,患病率为 14.0%(13,037/92,885)。这些妇女的 TBIL 浓度中位数为 7.9 mmol/l 比 7.6 mmol/l 高(P < 0.001)。对于 TBIL 在生理正常范围内(≤ 17.1 μmol/l)的 91,051 名妇女,TBIL 每增加一个四分位数间距(3.4 μmol/l),患 GDM 的风险就会降低:调整后的比值比 (OR)=0.89 [95% CI 0.87;0.92]。对于这些妇女,不同 TBIL 四分位数的 GDM 调整后 ORs 分别为与第一四分位数相比,第二四分位数的 GDM 调整 OR 为 0.92 [0.88;0.97],第三四分位数的 GDM 调整 OR 为 0.85 [0.81;0.90],第四四分位数的 GDM 调整 OR 为 0.78 [0.74;0.83]:我们的研究表明,血清 TBIL 水平升高与 GDM 风险降低有关,并支持其在预防和早期干预 GDM 中的潜在作用。
{"title":"High serum total bilirubin as a potential protective factor for gestational diabetes mellitus: A retrospective cohort study of 92,885 Chinese pregnant women","authors":"Yan Zhao ,&nbsp;Wenyu Zhu ,&nbsp;Miao Wang ,&nbsp;Luyi Cai ,&nbsp;Xueying Zheng ,&nbsp;Liping Jin","doi":"10.1016/j.diabet.2024.101523","DOIUrl":"10.1016/j.diabet.2024.101523","url":null,"abstract":"<div><h3>Aims</h3><p>Identifying physiological factors that could reduce pregnant women's risk for developing gestational diabetes mellitus (GDM) is crucial for early prevention and intervention. We aimed to examine whether higher serum levels of total bilirubin (TBIL) were associated with a decreased risk of GDM.</p></div><div><h3>Methods</h3><p>We conducted a retrospective cohort study in a tertiary care hospital in Shanghai, China. A total of 92,885 pregnant women were included. Serum TBIL levels were determined during the first antenatal visit before 24 weeks of gestation and GDM was diagnosed with a 75-g oral glucose tolerance test (OGTT) at 24–28 weeks of gestation.</p></div><div><h3>Results</h3><p>A total of 13,037 GDM cases were identified, a prevalence of 14.0 % (13,037/92,885). These women had a higher median TBIL concentration 7.9 versus 7.6 mmol/l (<em>P</em> &lt; 0.001). For the 91,051 women with TBIL within the physiologically normal range (≤ 17.1 μmol/l), a one interquartile range increase in TBIL (3.4 μmol/l) was associated with a decreased risk of GDM: adjusted odds ratio (OR)=0.89 [95 % CI 0.87;0.92]. For these women, the adjusted ORs for GDM across TBIL quartiles were: 0.92 [0.88;0.97] for the second, 0.85 [0.81;0.90] for the third, and 0.78 [0.74;0.83] for the fourth quartile in comparison with the first quartile.</p></div><div><h3>Conclusion</h3><p>Our study demonstrated that elevated serum TBIL levels were associated with decreased risk of GDM and supported its potential role in the prevention and early intervention of GDM.</p></div>","PeriodicalId":11334,"journal":{"name":"Diabetes & metabolism","volume":"50 2","pages":"Article 101523"},"PeriodicalIF":7.2,"publicationDate":"2024-02-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139716808","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk of rotator cuff tear and rotator cuff repair surgery comparison between sodium-glucose cotransporter 2 inhibitors and glucagon like peptide-1 receptor agonists: A real-world study 钠-葡萄糖共转运体 2 抑制剂与胰高血糖素样肽-1 受体激动剂的肩袖撕裂和肩袖修复手术风险比较:一项真实世界研究。
IF 7.2 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-02-08 DOI: 10.1016/j.diabet.2024.101522
Yu-Chi Su , Pei-Chun Hsieh , Edward Chia-Cheng Lai , Yu-Ching Lin

Aim

Theoretically, sodium-glucose cotransporter 2 inhibitors (SGLT2is) reduce the risk of rotator cuff tear through an anti-inflammatory mechanism. To clarify this association, in this study, we compared SGLT2is users and glucagon-like peptide-1 receptor agonists (GLP-1RAs) users in terms of the risk of rotator cuff tear and the risk of receiving rotator cuff repair surgery.

Methods

A retrospective cohort analysis was conducted using data from the TriNetX platform. A target trial design was adopted to identify patients with type 2 diabetes mellitus who started receiving SGLT2is or GLP-1RAs. Propensity score matching was used to form two homogeneous groups. The study outcomes were the risk of rotator cuff tear and the risk of receiving rotator cuff repair surgery. Hazard ratios (HRs) with 95 % confidence intervals (CIs) were calculated within the TriNetX platform.

Results

Initially, 351,800 SGLT2is users and 387,616 GLP-1RAs users were identified. After propensity score matching, each group comprised 274,026 patients. The mean age was 59.5 years in both groups; the proportions of women in the SGLT2is and GLP-1RAs groups were 46.9 % and 46.7 %, respectively. Compared with the GLP-1RAs group, the SGLT2is group had significantly reduced risks of rotator cuff tear (HR 0.812 [0.761;0.867]) and rotator cuff repair surgery (HR 0.900 [0.815;0.994]).

Conclusion

SGLT2is appear to reduce the risk of rotator cuff tear and the risk of receiving rotator cuff repair surgery in patients with type 2 diabetes mellitus. Further prospective studies are needed to validate our findings.

目的:理论上,钠-葡萄糖共转运体 2 抑制剂(SGLT2i)可通过抗炎机制降低肩袖撕裂的风险。为了澄清这种关联,我们在本研究中比较了 SGLT2i 使用者和胰高血糖素样肽-1 受体激动剂(GLP-1 RA)使用者的肩袖撕裂风险和接受肩袖修复手术的风险:利用 TriNetX 平台的数据进行了一项回顾性队列分析。采用目标试验设计来识别开始接受 SGLT2is 或 GLP-1 RAs 的 2 型糖尿病患者。采用倾向得分匹配法形成两个同质组。研究结果为肩袖撕裂风险和接受肩袖修复手术的风险。研究结果通过 TriNetX 平台计算出危险比 (HR) 和 95% 置信区间 (CI):最初确定了 351,800 名 SGLT2i 用户和 387,616 名 GLP-1 RA 用户。经过倾向评分匹配后,每组包括 274,026 名患者。两组患者的平均年龄均为 59.5 岁;SGLT2i 组和 GLP-1 RA 组的女性比例分别为 46.9% 和 46.7%。与 GLP-1 RA 组相比,SGLT2i 组发生肩袖撕裂(HR 0.812 [0.761;0.867])和肩袖修复手术(HR 0.900 [0.815;0.994])的风险显著降低:结论:SGLT2 可降低 2 型糖尿病患者肩袖撕裂的风险和接受肩袖修复手术的风险。需要进一步的前瞻性研究来验证我们的发现。
{"title":"Risk of rotator cuff tear and rotator cuff repair surgery comparison between sodium-glucose cotransporter 2 inhibitors and glucagon like peptide-1 receptor agonists: A real-world study","authors":"Yu-Chi Su ,&nbsp;Pei-Chun Hsieh ,&nbsp;Edward Chia-Cheng Lai ,&nbsp;Yu-Ching Lin","doi":"10.1016/j.diabet.2024.101522","DOIUrl":"10.1016/j.diabet.2024.101522","url":null,"abstract":"<div><h3>Aim</h3><p>Theoretically, sodium-glucose cotransporter 2 inhibitors (SGLT2is) reduce the risk of rotator cuff tear through an anti-inflammatory mechanism. To clarify this association, in this study, we compared SGLT2is users and glucagon-like peptide-1 receptor agonists (GLP-1RAs) users in terms of the risk of rotator cuff tear and the risk of receiving rotator cuff repair surgery.</p></div><div><h3>Methods</h3><p>A retrospective cohort analysis was conducted using data from the TriNetX platform. A target trial design was adopted to identify patients with type 2 diabetes mellitus who started receiving SGLT2is or GLP-1RAs. Propensity score matching was used to form two homogeneous groups. The study outcomes were the risk of rotator cuff tear and the risk of receiving rotator cuff repair surgery. Hazard ratios (HRs) with 95 % confidence intervals (CIs) were calculated within the TriNetX platform.</p></div><div><h3>Results</h3><p>Initially, 351,800 SGLT2is users and 387,616 GLP-1RAs users were identified. After propensity score matching, each group comprised 274,026 patients. The mean age was 59.5 years in both groups; the proportions of women in the SGLT2is and GLP-1RAs groups were 46.9 % and 46.7 %, respectively. Compared with the GLP-1RAs group, the SGLT2is group had significantly reduced risks of rotator cuff tear (HR 0.812 [0.761;0.867]) and rotator cuff repair surgery (HR 0.900 [0.815;0.994]).</p></div><div><h3>Conclusion</h3><p>SGLT2is appear to reduce the risk of rotator cuff tear and the risk of receiving rotator cuff repair surgery in patients with type 2 diabetes mellitus. Further prospective studies are needed to validate our findings.</p></div>","PeriodicalId":11334,"journal":{"name":"Diabetes & metabolism","volume":"50 2","pages":"Article 101522"},"PeriodicalIF":7.2,"publicationDate":"2024-02-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139716809","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Glycemic Risk Index (GRI) variability in type 1 diabetes adults with HbA1c ≤ 7%: Insights for clinical evaluation and intervention HbA1c≤ 7% 的 1 型糖尿病成人的血糖风险指数 (GRI) 变异性:临床评估和干预的启示
IF 7.2 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-02-01 DOI: 10.1016/j.diabet.2024.101520
Philippe Oriot , Michel P Hermans , Antoine Vandelaer , Jean Christophe Philips , Gaëtan Prévost
{"title":"Glycemic Risk Index (GRI) variability in type 1 diabetes adults with HbA1c ≤ 7%: Insights for clinical evaluation and intervention","authors":"Philippe Oriot ,&nbsp;Michel P Hermans ,&nbsp;Antoine Vandelaer ,&nbsp;Jean Christophe Philips ,&nbsp;Gaëtan Prévost","doi":"10.1016/j.diabet.2024.101520","DOIUrl":"10.1016/j.diabet.2024.101520","url":null,"abstract":"","PeriodicalId":11334,"journal":{"name":"Diabetes & metabolism","volume":"50 2","pages":"Article 101520"},"PeriodicalIF":7.2,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139666478","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Associations of type 2 diabetes and the risk of migraine in Chinese populations 中国人群中 2 型糖尿病与偏头痛风险的关系
IF 7.2 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-01-23 DOI: 10.1016/j.diabet.2024.101518
Jielong Wu , Jie Fang , Xiaodong Yuan , Lingshan Ma , Liangcheng Zheng , Qing Lin , Xingkai An , Zhanxiang Wang , Qilin Ma

Aim

We aimed to explore the relationship between type 2 diabetes mellitus (T2DM) and the incidence rate of migraine in a Chinese population, and analyze the clinical characteristics of migraine patients with T2DM.

Methods

Data on the study cohort of 9873 individuals were obtained from the China Health and Retirement Longitudinal Study (CHARLS). The incidence rate of migraine from 2015 to 2018 was assessed. The Cox proportional hazards model was used to estimate hazard ratios (HRs) and their 95% confidence intervals (CIs) for the relationship between T2DM and the incidence of migraine. In addition, a cross-sectional study including 168 migraine patients was conducted in Xiamen, China. Migraine patients were grouped according to their T2DM status. Multivariable linear regression models were used to estimate βs and their 95% CIs for the relationship between migraine characteristics and T2DM.

Results

The cumulative incidence rate of migraine from 2015 to 2018 in the T2DM group and control group was 7.26% [6.04%.8.65%] and 8.91% [8.27%.9.58%], respectively. The risk of migraine in patients with T2DM was reduced by 21% (HR 0.79 [0.65;0.95]) compared to patients with no T2DM after adjustment for confounders. The cross-sectional study showed that the presence of T2DM significantly reduced migraine frequency and relieved migraine intensity.

Conclusion

This was the first study to validate that T2DM reduced the risk of migraine in a Chinese population cohort. Patients with migraine and T2DM may experience significant relief from their headache symptoms. Carrying out relevant mechanistic research may help to identify new targets for migraine treatment and contribute to further understanding the impact of T2DM or related metabolic disorders on an individual's health.

AimWe aimed to explore the relationship between type 2 diabetes mellitus (T2DM) and the incidence rate of migraine in a Chinese population, and analyze the clinical characteristics of migraine patients with T2DM.Methods研究队列9873人的数据来自中国健康与退休纵向研究(CHARLS)。评估了2015年至2018年偏头痛的发病率。采用Cox比例危险模型估计T2DM与偏头痛发病率之间关系的危险比(HRs)及其95%置信区间(CIs)。此外,还在中国厦门开展了一项横断面研究,纳入了168名偏头痛患者。偏头痛患者根据其 T2DM 状态进行分组。结果2015年至2018年,T2DM组和对照组偏头痛的累计发病率分别为7.26% [6.04%.8.65%]和8.91% [8.27%.9.58%]。在对混杂因素进行调整后,T2DM患者发生偏头痛的风险比未患T2DM的患者降低了21%(HR为0.79 [0.65;0.95])。这项横断面研究表明,T2DM 可显著降低偏头痛发生频率,缓解偏头痛强度。偏头痛合并 T2DM 患者的头痛症状可能会明显缓解。开展相关的机理研究有助于确定偏头痛治疗的新靶点,并有助于进一步了解T2DM或相关代谢紊乱对个人健康的影响。
{"title":"Associations of type 2 diabetes and the risk of migraine in Chinese populations","authors":"Jielong Wu ,&nbsp;Jie Fang ,&nbsp;Xiaodong Yuan ,&nbsp;Lingshan Ma ,&nbsp;Liangcheng Zheng ,&nbsp;Qing Lin ,&nbsp;Xingkai An ,&nbsp;Zhanxiang Wang ,&nbsp;Qilin Ma","doi":"10.1016/j.diabet.2024.101518","DOIUrl":"10.1016/j.diabet.2024.101518","url":null,"abstract":"<div><h3>Aim</h3><p>We aimed to explore the relationship between type 2 diabetes mellitus (T2DM) and the incidence rate of migraine in a Chinese population, and analyze the clinical characteristics of migraine patients with T2DM.</p></div><div><h3>Methods</h3><p><span><span>Data on the study cohort of 9873 individuals were obtained from the China Health and Retirement Longitudinal Study (CHARLS). The incidence rate of migraine from 2015 to 2018 was assessed. The Cox </span>proportional hazards model was used to estimate hazard ratios (HRs) and their 95% confidence intervals (CIs) for the relationship between T2DM and the incidence of migraine. In addition, a cross-sectional study including 168 migraine patients was conducted in Xiamen, China. Migraine patients were grouped according to their T2DM status. Multivariable </span>linear regression models were used to estimate βs and their 95% CIs for the relationship between migraine characteristics and T2DM.</p></div><div><h3>Results</h3><p>The cumulative incidence rate of migraine from 2015 to 2018 in the T2DM group and control group was 7.26% [6.04%.8.65%] and 8.91% [8.27%.9.58%], respectively. The risk of migraine in patients with T2DM was reduced by 21% (HR 0.79 [0.65;0.95]) compared to patients with no T2DM after adjustment for confounders. The cross-sectional study showed that the presence of T2DM significantly reduced migraine frequency and relieved migraine intensity.</p></div><div><h3>Conclusion</h3><p>This was the first study to validate that T2DM reduced the risk of migraine in a Chinese population cohort. Patients with migraine and T2DM may experience significant relief from their headache symptoms. Carrying out relevant mechanistic research may help to identify new targets for migraine treatment<span> and contribute to further understanding the impact of T2DM or related metabolic disorders on an individual's health.</span></p></div>","PeriodicalId":11334,"journal":{"name":"Diabetes & metabolism","volume":"50 2","pages":"Article 101518"},"PeriodicalIF":7.2,"publicationDate":"2024-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139560147","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Social isolation, loneliness, and the risk of incident type 2 diabetes mellitus by glycemic status 按血糖状况划分的社会隔离、孤独感和 2 型糖尿病发病风险
IF 7.2 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-01-20 DOI: 10.1016/j.diabet.2024.101517
Yanjun Zhang , Mengyi Liu , Chun Zhou , Ziliang Ye , Yuanyuan Zhang , Sisi Yang , Panpan He , Xiaoqin Gan , Xianhui Qin

Aim

The modifying effect of prediabetic status on the association of social isolation and loneliness with the risk of type 2 diabetes mellitus (T2DM) remains uncertain. We aimed to explore whether prediabetic status modifies the association of social isolation and loneliness with incident T2DM.

Methods

358,951 participants with random blood glucose < 11.1 mmol/l, hemoglobin A1c < 6.5 % and without diagnosis of diabetes from the UK Biobank were included. Prediabetes was defined by hemoglobin A1c level at 5.7–6.4 %. Social isolation and loneliness were assessed using self-reported questionnaires. The study outcome was incident T2DM.

Results

During a median follow-up of 12.5 years, 13,213 (3.7 %) incident T2DM cases were documented. Social isolation and loneliness in subjects with normoglycemia (adjusted HR [95 %CI]: social isolation: 1.14 [1.07;1.23]; loneliness: 1.33 [1.20;1.47]) were more strongly associated with increased risk of T2DM than in those with prediabetes (adjusted HR [95 %CI]: social isolation: 0.97 [0.91;1.03]; loneliness: 1.04 [0.95;1.13]) (Both P for interaction < 0.001). Among individuals with prediabetes, alcoholic consumption (30.9 %), household income (23.3 %), healthy sleep (17.1 %), loneliness (14.9 %), and physical activity (12.6 %) mediated most of the variance in the association between social isolation and incident T2DM, while body mass index (17.9 %) and healthy sleep (17.6 %) mediated most of the variance in the association between loneliness and incident T2DM.

Conclusion

Social isolation and loneliness were independently associated with a higher risk of T2DM among individuals without prediabetes. Among those with prediabetes, the association of social isolation and loneliness with incident T2DM were mainly mediated by some socioeconomic and lifestyle factors.

目的 糖尿病前期状态对社会隔离和孤独与 2 型糖尿病(T2DM)发病风险之间关系的调节作用仍不确定。我们的目的是探讨糖尿病前期状态是否会改变社会隔离和孤独感与 T2DM 发病的关系。方法纳入英国生物库中随机血糖为 11.1mmol/lt、血红蛋白 A1c 为 6.5%、未确诊糖尿病的 358951 名参与者。糖尿病前期的定义是血红蛋白 A1c 水平在 5.7-6.4% 之间。社会隔离和孤独感通过自我报告问卷进行评估。中位随访时间为 12.5 年,共记录了 13213 例(3.7%)T2DM 患者。血糖正常者的社会隔离和孤独感(调整后 HR [95%CI]:社会隔离:1.14 [1.07;1.23];孤独感:1.33 [1.20;1.47])比糖尿病前期患者(调整 HR [95%CI]:社会隔离:0.97 [0.91;0.47])患 T2DM 的风险更高:0.97[0.91;1.03];孤独感:1.04[0.95;1.13])(交互作用的 P 均为 0.001)。在糖尿病前期患者中,饮酒(30.9%)、家庭收入(23.3%)、健康睡眠(17.1%)、孤独感(14.9%)和体育锻炼(12.6%)介导了社会隔离与 T2DM 发生之间关系的大部分变异,而体重指数(17.结论在未患糖尿病前期的人群中,社会隔离和孤独与较高的 T2DM 风险独立相关。在糖尿病前期患者中,社会隔离和孤独感与T2DM事件的关系主要受一些社会经济和生活方式因素的影响。
{"title":"Social isolation, loneliness, and the risk of incident type 2 diabetes mellitus by glycemic status","authors":"Yanjun Zhang ,&nbsp;Mengyi Liu ,&nbsp;Chun Zhou ,&nbsp;Ziliang Ye ,&nbsp;Yuanyuan Zhang ,&nbsp;Sisi Yang ,&nbsp;Panpan He ,&nbsp;Xiaoqin Gan ,&nbsp;Xianhui Qin","doi":"10.1016/j.diabet.2024.101517","DOIUrl":"10.1016/j.diabet.2024.101517","url":null,"abstract":"<div><h3>Aim</h3><p>The modifying effect of prediabetic status on the association of social isolation and loneliness with the risk of type 2 diabetes mellitus (T2DM) remains uncertain. We aimed to explore whether prediabetic status modifies the association of social isolation and loneliness with incident T2DM.</p></div><div><h3>Methods</h3><p><span>358,951 participants with random blood glucose &lt; 11.1 mmol/l, </span>hemoglobin A1c<span><span> &lt; 6.5 % and without diagnosis of diabetes from the UK Biobank were included. </span>Prediabetes was defined by hemoglobin A1c level at 5.7–6.4 %. Social isolation and loneliness were assessed using self-reported questionnaires. The study outcome was incident T2DM.</span></p></div><div><h3>Results</h3><p>During a median follow-up of 12.5 years, 13,213 (3.7 %) incident T2DM cases were documented. Social isolation and loneliness in subjects with normoglycemia (adjusted HR [95 %CI]: social isolation: 1.14 [1.07;1.23]; loneliness: 1.33 [1.20;1.47]) were more strongly associated with increased risk of T2DM than in those with prediabetes (adjusted HR [95 %CI]: social isolation: 0.97 [0.91;1.03]; loneliness: 1.04 [0.95;1.13]) (Both <em>P</em><span> for interaction &lt; 0.001). Among individuals with prediabetes, alcoholic consumption (30.9 %), household income (23.3 %), healthy sleep (17.1 %), loneliness (14.9 %), and physical activity (12.6 %) mediated most of the variance in the association between social isolation and incident T2DM, while body mass index (17.9 %) and healthy sleep (17.6 %) mediated most of the variance in the association between loneliness and incident T2DM.</span></p></div><div><h3>Conclusion</h3><p>Social isolation and loneliness were independently associated with a higher risk of T2DM among individuals without prediabetes. Among those with prediabetes, the association of social isolation and loneliness with incident T2DM were mainly mediated by some socioeconomic and lifestyle factors.</p></div>","PeriodicalId":11334,"journal":{"name":"Diabetes & metabolism","volume":"50 2","pages":"Article 101517"},"PeriodicalIF":7.2,"publicationDate":"2024-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139507803","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hope, hype and present limitations of hybrid closed loop systems for persons with type 1 diabetes 针对 1 型糖尿病患者的混合闭环系统的希望、炒作和目前的局限性
IF 7.2 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-01-15 DOI: 10.1016/j.diabet.2024.101510
Charles Thivolet
{"title":"Hope, hype and present limitations of hybrid closed loop systems for persons with type 1 diabetes","authors":"Charles Thivolet","doi":"10.1016/j.diabet.2024.101510","DOIUrl":"10.1016/j.diabet.2024.101510","url":null,"abstract":"","PeriodicalId":11334,"journal":{"name":"Diabetes & metabolism","volume":"50 2","pages":"Article 101510"},"PeriodicalIF":7.2,"publicationDate":"2024-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139471226","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Eleven-year trends in socioeconomic inequalities in the prevalence and incidence of pharmacologically treated type 2 diabetes in France, 2010–2020 2010-2020 年法国药物治疗的 2 型糖尿病患病率和发病率的社会经济不平等的十一年趋势
IF 7.2 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-01-10 DOI: 10.1016/j.diabet.2024.101509
Marie Guion , Laurence Mandereau-Bruno , Sarah Goria , Emmanuel Cosson , Sandrine Fosse-Edorh

Aim

This study aimed to describe the association between socioeconomic inequalities and the prevalence and incidence of pharmacologically-treated type 2 diabetes in European France over the 2010–2020 period.

Methods

Diabetes cases were identified using a validated algorithm from the French National Health Data System. Analysis was restricted to adults aged 45 years and older to focus on type 2 diabetes. Socioeconomic inequalities were measured for all years in European France using the French deprivation index (FDep, 2015 version), which is an area-based deprivation indicator using population-weighted quintiles (Q1 corresponds to the least deprived municipalities). The relative risks of diabetes prevalence and incidence associated with FDep quintiles (Q1 as the reference) were estimated by sex using a log-linear Poisson model adjusted for year, age and French department. The study population was the French health consumers aged 45 years and over (from 24,228,526 in 2010 to 29,772,928 in 2020).

Results

A positive gradient was observed in the relative risks of type 2 diabetes prevalence and incidence by FDep quintiles over the study period. The strength of the estimated associations increased over the last decade for prevalence among men and women and for incidence among men in the two most deprived quintiles.

Conclusion

Thus, type 2 diabetes prevention should include a proportionate universalism approach, proposing actions of greater intensity in the most deprived areas.

目的--本研究旨在描述2010-2020年期间欧洲法国的社会经济不平等与药物治疗的2型糖尿病患病率和发病率之间的关系。方法--采用法国国家健康数据系统的有效算法确定糖尿病病例。分析对象仅限于 45 岁及以上的成年人,重点关注 2 型糖尿病。法国贫困指数(FDep,2015 年版)是一项基于地区的贫困指标,采用人口加权五等分法(Q1 对应最贫困的城市)。采用对数线性泊松模型,按性别估算了与 FDep 五分位数(Q1 为参考值)相关的糖尿病患病率和发病率的相对风险,并对年份、年龄和法国省份进行了调整。研究对象为年龄在 45 岁及以上的法国健康消费者(从 2010 年的 24,228,526 人到 2020 年的 29,772,928 人)。结果--在研究期间,2 型糖尿病患病率和发病率的相对风险与 FDep 五分位数呈正梯度关系。在过去十年中,男性和女性的患病率以及男性在两个最贫困五分位数中的发病率的估计关联强度都有所上升。结论--因此,2 型糖尿病预防应包括一种比例普遍性方法,建议在最贫困地区采取更大力度的行动。
{"title":"Eleven-year trends in socioeconomic inequalities in the prevalence and incidence of pharmacologically treated type 2 diabetes in France, 2010–2020","authors":"Marie Guion ,&nbsp;Laurence Mandereau-Bruno ,&nbsp;Sarah Goria ,&nbsp;Emmanuel Cosson ,&nbsp;Sandrine Fosse-Edorh","doi":"10.1016/j.diabet.2024.101509","DOIUrl":"10.1016/j.diabet.2024.101509","url":null,"abstract":"<div><h3>Aim</h3><p>This study aimed to describe the association between socioeconomic inequalities and the prevalence and incidence of pharmacologically-treated type 2 diabetes in European France over the 2010–2020 period.</p></div><div><h3>Methods</h3><p>Diabetes cases were identified using a validated algorithm from the French National Health Data System. Analysis was restricted to adults aged 45 years and older to focus on type 2 diabetes. Socioeconomic inequalities were measured for all years in European France using the French deprivation index (FDep, 2015 version), which is an area-based deprivation indicator using population-weighted quintiles (Q1 corresponds to the least deprived municipalities). The relative risks of diabetes prevalence and incidence associated with FDep quintiles (Q1 as the reference) were estimated by sex using a log-linear Poisson model adjusted for year, age and French department. The study population was the French health consumers aged 45 years and over (from 24,228,526 in 2010 to 29,772,928 in 2020).</p></div><div><h3>Results</h3><p>A positive gradient was observed in the relative risks of type 2 diabetes prevalence and incidence by FDep quintiles over the study period. The strength of the estimated associations increased over the last decade for prevalence among men and women and for incidence among men in the two most deprived quintiles.</p></div><div><h3>Conclusion</h3><p>Thus, type 2 diabetes prevention should include a proportionate universalism approach, proposing actions of greater intensity in the most deprived areas.</p></div>","PeriodicalId":11334,"journal":{"name":"Diabetes & metabolism","volume":"50 2","pages":"Article 101509"},"PeriodicalIF":7.2,"publicationDate":"2024-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139411692","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Diabetes & metabolism
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1